Healthcare Sector Stocks
The Healthcare sector has a total of 1064 stocks, with a combined market cap of $8.38 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 40.37.
Market Cap
8.38T
Revenue
4.52T
Profits
207.56B
PE Ratio
40.37
Profit Margin
4.59%
Dividend Yield
0.43%
1064 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 856.66B | 2.82% | 1,121,197 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 576.55B | 0.40% | 3,905,735 | 94.19B |
| 3 | ABBV | AbbVie Inc. | 373.07B | 2.20% | 1,526,807 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 307.39B | 1.86% | 1,000,927 | 58.74B |
| 5 | MRK | Merck & Co., Inc. | 302.47B | 2.57% | 3,515,056 | 65.01B |
| 6 | NVS | Novartis AG | 285.81B | 1.88% | 1,432,231 | 56.67B |
| 7 | UNH | UnitedHealth Group Incorporated | 278.60B | -0.26% | 4,095,094 | 447.57B |
| 8 | AMGN | Amgen Inc. | 188.98B | 3.11% | 762,129 | 36.75B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 186.61B | 2.62% | 534,400 | 44.56B |
| 10 | ABT | Abbott Laboratories | 180.23B | 1.62% | 2,775,369 | 44.33B |
| 11 | GILD | Gilead Sciences, Inc. | 174.57B | 1.33% | 1,151,483 | 29.44B |
| 12 | ISRG | Intuitive Surgical, Inc. | 166.49B | 3.49% | 754,664 | 10.06B |
| 13 | NVO | Novo Nordisk A/S | 161.63B | 2.36% | 7,411,340 | 48.59B |
| 14 | PFE | Pfizer Inc. | 154.15B | - | 14,679,304 | 62.58B |
| 15 | DHR | Danaher Corporation | 138.95B | 2.79% | 1,047,192 | 24.57B |
| 16 | SYK | Stryker Corporation | 129.34B | 1.78% | 622,395 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 119.87B | 1.80% | 4,274,093 | 48.19B |
| 18 | MDT | Medtronic plc | 112.97B | 1.82% | 3,426,546 | 35.48B |
| 19 | HCA | HCA Healthcare, Inc. | 112.62B | 2.89% | 380,905 | 75.60B |
| 20 | SNY | Sanofi | 112.50B | 0.53% | 2,154,998 | 54.85B |
| 21 | VRTX | Vertex Pharmaceuticals Incorporated | 112.10B | 2.05% | 339,212 | 12.00B |
| 22 | GSK | GSK plc | 111.00B | 2.33% | 1,783,582 | 43.97B |
| 23 | MCK | McKesson Corporation | 106.32B | 1.33% | 325,687 | 397.96B |
| 24 | CVS | CVS Health Corporation | 100.55B | 0.31% | 2,296,434 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 92.53B | 0.65% | 5,921,552 | 20.07B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 79.49B | 1.89% | 206,779 | 14.34B |
| 27 | CI | The Cigna Group | 72.56B | 0.35% | 336,604 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 69.81B | 1.92% | 369,288 | 199.13B |
| 29 | COR | Cencora, Inc. | 62.85B | 0.69% | 283,923 | 325.78B |
| 30 | MDLN | Medline Inc. | 58.10B | 2.57% | 2,388,206 | 28.43B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 57.20B | 2.19% | 1,420,445 | 28.48B |
| 32 | CAH | Cardinal Health, Inc. | 50.54B | 0.94% | 410,674 | 244.67B |
| 33 | ZTS | Zoetis Inc. | 50.47B | 2.37% | 894,301 | 9.47B |
| 34 | EW | Edwards Lifesciences Corporation | 47.51B | 1.93% | 1,688,860 | 6.07B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 47.21B | 3.15% | 138,325 | 4.30B |
| 36 | ARGX | argenx SE | 46.67B | 2.55% | 136,882 | 4.24B |
| 37 | BDX | Becton, Dickinson and Company | 44.70B | 1.32% | 1,156,786 | 21.92B |
| 38 | HLN | Haleon plc | 43.63B | 1.16% | 4,864,545 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.35B | 2.31% | 338,221 | 3.71B |
| 40 | ALC | Alcon Inc. | 37.77B | 4.10% | 770,160 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 35.61B | 4.26% | 2,279,142 | 17.26B |
| 42 | INSM | Insmed Incorporated | 34.79B | -1.15% | 1,484,007 | 606.42M |
| 43 | ONC | BeOne Medicines AG | 34.74B | 3.11% | 90,726 | 5.34B |
| 44 | RMD | ResMed Inc. | 33.81B | 3.12% | 331,314 | 5.40B |
| 45 | GEHC | GE HealthCare Technologies Inc. | 33.55B | 5.45% | 2,098,790 | 20.63B |
| 46 | A | Agilent Technologies, Inc. | 32.98B | 2.49% | 374,739 | 7.07B |
| 47 | WAT | Waters Corporation | 31.13B | 3.22% | 251,110 | 3.17B |
| 48 | NTRA | Natera, Inc. | 30.09B | 1.46% | 400,877 | 2.31B |
| 49 | IQV | IQVIA Holdings Inc. | 29.29B | 2.27% | 463,007 | 16.31B |
| 50 | VEEV | Veeva Systems Inc. | 28.25B | 0.27% | 513,160 | 3.20B |
| 51 | RPRX | Royalty Pharma plc | 27.64B | 2.22% | 892,474 | 2.38B |
| 52 | MTD | Mettler-Toledo International Inc. | 26.78B | 4.12% | 46,904 | 4.03B |
| 53 | BIIB | Biogen Inc. | 26.01B | 0.94% | 362,999 | 9.89B |
| 54 | UTHR | United Therapeutics Corporation | 25.58B | 3.17% | 178,245 | 3.18B |
| 55 | PHG | Koninklijke Philips N.V. | 25.46B | 3.78% | 325,715 | 20.94B |
| 56 | DXCM | DexCom, Inc. | 25.31B | 4.20% | 1,051,595 | 4.66B |
| 57 | HUM | Humana Inc. | 23.68B | 0.03% | 747,675 | 129.66B |
| 58 | BNTX | BioNTech SE | 23.12B | 2.01% | 192,026 | 3.37B |
| 59 | LH | Labcorp Holdings Inc. | 22.69B | 2.31% | 116,398 | 13.95B |
| 60 | STE | STERIS plc | 21.98B | 2.24% | 136,450 | 5.83B |
| 61 | DGX | Quest Diagnostics Incorporated | 21.86B | 0.36% | 213,534 | 11.04B |
| 62 | MRNA | Moderna, Inc. | 20.54B | 3.33% | 1,890,460 | 1.94B |
| 63 | ROIV | Roivant Sciences Ltd. | 20.29B | 2.16% | 1,083,667 | 13.31M |
| 64 | ILMN | Illumina, Inc. | 19.57B | 1.23% | 565,701 | 4.34B |
| 65 | RVMD | Revolution Medicines, Inc. | 19.15B | 0.35% | 326,871 | - |
| 66 | WST | West Pharmaceutical Services, Inc. | 19.01B | 1.79% | 154,729 | 3.07B |
| 67 | INCY | Incyte Corporation | 18.84B | 1.05% | 274,911 | 5.14B |
| 68 | CNC | Centene Corporation | 18.22B | 2.04% | 2,510,000 | 176.15B |
| 69 | ZBH | Zimmer Biomet Holdings, Inc. | 17.98B | 1.64% | 854,276 | 8.23B |
| 70 | THC | Tenet Healthcare Corporation | 17.61B | 4.09% | 359,455 | 21.31B |
| 71 | HOLX | Hologic, Inc. | 16.97B | 0.48% | 101,701,146 | 4.13B |
| 72 | GMAB | Genmab A/S | 16.66B | 1.70% | 691,571 | 3.72B |
| 73 | VTRS | Viatris Inc. | 15.87B | 3.57% | 1,834,462 | 14.30B |
| 74 | MEDP | Medpace Holdings, Inc. | 15.00B | 3.28% | 121,170 | 2.53B |
| 75 | SMMT | Summit Therapeutics Inc. | 14.92B | 0.10% | 625,571 | - |
| 76 | RGC | Regencell Bioscience Holdings Limited | 14.47B | 5.03% | 87,012 | - |
| 77 | BBIO | BridgeBio Pharma, Inc. | 14.44B | 3.56% | 445,121 | 502.08M |
| 78 | PODD | Insulet Corporation | 14.22B | 1.42% | 195,638 | 2.71B |
| 79 | ASND | Ascendis Pharma A/S | 14.01B | 3.56% | 294,046 | 845.52M |
| 80 | COO | The Cooper Companies, Inc. | 13.99B | 2.90% | 742,649 | 4.15B |
| 81 | SNN | Smith & Nephew plc | 13.50B | 4.13% | 367,087 | 6.16B |
| 82 | NBIX | Neurocrine Biosciences, Inc. | 13.27B | 0.98% | 349,278 | 2.86B |
| 83 | PEN | Penumbra, Inc. | 13.01B | 0.28% | 106,781 | 1.40B |
| 84 | ALGN | Align Technology, Inc. | 12.71B | 6.89% | 377,070 | 4.03B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.47B | 2.17% | 460,950 | 943.71M |
| 86 | GMED | Globus Medical, Inc. | 12.44B | 2.22% | 534,507 | 2.94B |
| 87 | GH | Guardant Health, Inc. | 12.37B | 1.07% | 626,697 | 982.02M |
| 88 | FMS | Fresenius Medical Care AG | 12.23B | 3.43% | 218,496 | 23.05B |
| 89 | ENSG | The Ensign Group, Inc. | 12.05B | 2.92% | 100,017 | 5.06B |
| 90 | JAZZ | Jazz Pharmaceuticals plc | 12.01B | 2.19% | 341,216 | 4.27B |
| 91 | ELAN | Elanco Animal Health Incorporated | 11.83B | 4.36% | 1,239,665 | 4.72B |
| 92 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.79B | 0.44% | 172,787 | 958.40M |
| 93 | EXEL | Exelixis, Inc. | 11.56B | 1.18% | 774,873 | 2.32B |
| 94 | UHS | Universal Health Services, Inc. | 11.43B | 3.55% | 152,746 | 17.36B |
| 95 | SOLV | Solventum Corporation | 11.24B | 3.73% | 418,466 | 8.33B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 11.07B | 2.38% | 447,473 | 3.22B |
| 97 | EHC | Encompass Health Corporation | 10.73B | 2.11% | 326,433 | 5.94B |
| 98 | RDY | Dr. Reddy's Laboratories Limited | 10.68B | 2.36% | 1,209,565 | 3.85B |
| 99 | RVTY | Revvity, Inc. | 10.11B | 2.97% | 339,717 | 2.86B |
| 100 | DVA | DaVita Inc. | 10.09B | 0.89% | 172,269 | 13.64B |
| 101 | BTSG | BrightSpring Health Services, Inc. | 9.34B | 4.31% | 907,121 | 12.91B |
| 102 | MASI | Masimo Corporation | 9.32B | -0.15% | 279,047 | 1.53B |
| 103 | ABVX | ABIVAX Société Anonyme | 9.12B | 1.60% | 297,470 | 5.37M |
| 104 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.98B | 4.77% | 649,125 | 1.09B |
| 105 | BAX | Baxter International Inc. | 8.93B | 4.06% | 2,756,757 | 11.24B |
| 106 | AXSM | Axsome Therapeutics, Inc. | 8.85B | 2.58% | 173,574 | 638.50M |
| 107 | PCVX | Vaxcyte, Inc. | 8.80B | 0.77% | 344,390 | - |
| 108 | PRAX | Praxis Precision Medicines, Inc. | 8.80B | 3.03% | 135,448 | 7.46M |
| 109 | CRL | Charles River Laboratories International, Inc. | 8.65B | 3.69% | 256,130 | 4.02B |
| 110 | HSIC | Henry Schein, Inc. | 8.63B | 1.92% | 737,435 | 13.18B |
| 111 | TEM | Tempus AI, Inc. | 8.59B | 2.60% | 2,521,236 | 1.27B |
| 112 | TECH | Bio-Techne Corporation | 8.57B | 1.76% | 855,949 | 1.22B |
| 113 | QGEN | Qiagen N.V. | 8.57B | 3.21% | 523,465 | 2.09B |
| 114 | ATR | AptarGroup, Inc. | 8.40B | 4.82% | 130,400 | 3.78B |
| 115 | ICLR | ICON Public Limited Company | 8.26B | 0.97% | 199,249 | 8.10B |
| 116 | CYTK | Cytokinetics, Incorporated | 8.23B | 2.05% | 517,838 | 88.04M |
| 117 | NUVL | Nuvalent, Inc. | 8.17B | 1.63% | 100,419 | - |
| 118 | KRYS | Krystal Biotech, Inc. | 7.85B | 0.97% | 160,677 | 389.13M |
| 119 | HALO | Halozyme Therapeutics, Inc. | 7.74B | 2.74% | 587,269 | 1.40B |
| 120 | BIO | Bio-Rad Laboratories, Inc. | 7.65B | 1.98% | 80,943 | 2.58B |
| 121 | MOH | Molina Healthcare, Inc. | 7.57B | 2.64% | 358,812 | 43.56B |
| 122 | IBRX | ImmunityBio, Inc. | 7.21B | 1.75% | 7,845,002 | 113.29M |
| 123 | BLTE | Belite Bio, Inc | 7.05B | 5.53% | 82,294 | - |
| 124 | KYMR | Kymera Therapeutics, Inc. | 7.02B | 0.99% | 135,017 | 39.21M |
| 125 | GKOS | Glaukos Corporation | 7.00B | 4.82% | 337,879 | 507.44M |
| 126 | HQY | HealthEquity, Inc. | 6.92B | 0.96% | 282,923 | 1.31B |
| 127 | RGEN | Repligen Corporation | 6.75B | 3.87% | 215,751 | 738.26M |
| 128 | ACLX | Arcellx, Inc. | 6.74B | -0.01% | 262,232 | 22.29M |
| 129 | PTGX | Protagonist Therapeutics, Inc. | 6.57B | -0.81% | 168,433 | 46.02M |
| 130 | GRFS | Grifols, S.A. | 6.49B | 3.33% | 139,855 | 8.83B |
| 131 | CNTA | Centessa Pharmaceuticals plc | 6.11B | -0.16% | 991,000 | 15.00M |
| 132 | TERN | Terns Pharmaceuticals, Inc. | 6.07B | -0.04% | 9,416,088 | - |
| 133 | APGE | Apogee Therapeutics, Inc. | 6.07B | -1.38% | 307,433 | - |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.94B | 0.35% | 268,793 | 189.76M |
| 135 | COGT | Cogent Biosciences, Inc. | 5.89B | 2.67% | 648,235 | - |
| 136 | PTCT | PTC Therapeutics, Inc. | 5.88B | 2.08% | 307,424 | 1.73B |
| 137 | MIRM | Mirum Pharmaceuticals, Inc. | 5.87B | 1.65% | 142,130 | 521.31M |
| 138 | BLCO | Bausch + Lomb Corporation | 5.84B | 3.45% | 95,271 | 5.10B |
| 139 | CGON | CG Oncology, Inc. | 5.83B | -1.15% | 497,915 | 4.04M |
| 140 | BRKR | Bruker Corporation | 5.81B | 4.09% | 388,877 | 3.44B |
| 141 | SRRK | Scholar Rock Holding Corporation | 5.78B | 0.82% | 461,414 | - |
| 142 | ALKS | Alkermes plc | 5.68B | 3.39% | 922,099 | 1.48B |
| 143 | CELC | Celcuity Inc. | 5.61B | 0.42% | 172,758 | - |
| 144 | CAI | Caris Life Sciences, Inc. | 5.53B | 4.37% | 450,352 | 812.03M |
| 145 | AVTR | Avantor, Inc. | 5.51B | 1.81% | 3,831,491 | 6.55B |
| 146 | PACS | PACS Group, Inc. | 5.47B | 7.33% | 165,490 | 5.29B |
| 147 | CHE | Chemed Corporation | 5.47B | 2.21% | 76,685 | 2.53B |
| 148 | XENE | Xenon Pharmaceuticals Inc. | 5.42B | -1.53% | 162,433 | 7.50M |
| 149 | ERAS | Erasca, Inc. | 5.31B | 0.06% | 1,450,606 | - |
| 150 | TFX | Teleflex Incorporated | 5.27B | 3.20% | 247,763 | 1.99B |
| 151 | LNTH | Lantheus Holdings, Inc. | 5.21B | 2.72% | 291,059 | 1.54B |
| 152 | APLS | Apellis Pharmaceuticals, Inc. | 5.20B | - | 1,964,256 | 1.00B |
| 153 | IMVT | Immunovant, Inc. | 5.09B | 1.63% | 347,504 | - |
| 154 | TGTX | TG Therapeutics, Inc. | 5.00B | 1.39% | 500,408 | 616.29M |
| 155 | CRSP | CRISPR Therapeutics AG | 4.96B | 3.94% | 753,271 | 3.51M |
| 156 | DNTH | Dianthus Therapeutics, Inc. | 4.59B | 0.50% | 342,879 | 2.04M |
| 157 | CORT | Corcept Therapeutics Incorporated | 4.57B | 2.97% | 369,480 | 761.41M |
| 158 | FOLD | Amicus Therapeutics, Inc. | 4.54B | - | 920,350 | 634.21M |
| 159 | OPCH | Option Care Health, Inc. | 4.52B | 4.25% | 646,833 | 5.65B |
| 160 | HIMS | Hims & Hers Health, Inc. | 4.52B | 1.74% | 10,301,464 | 2.35B |
| 161 | WAY | Waystar Holding Corp. | 4.46B | 1.79% | 1,267,754 | 1.10B |
| 162 | NVST | Envista Holdings Corporation | 4.39B | 5.85% | 1,333,246 | 2.72B |
| 163 | RDNT | RadNet, Inc. | 4.35B | 2.69% | 320,087 | 2.04B |
| 164 | ALHC | Alignment Healthcare, Inc. | 4.32B | -2.40% | 2,232,208 | 3.95B |
| 165 | SHC | Sotera Health Company | 4.32B | 3.69% | 700,040 | 1.16B |
| 166 | OSCR | Oscar Health, Inc. | 4.28B | 11.03% | 8,328,531 | 11.70B |
| 167 | BLLN | BillionToOne, Inc. | 4.21B | 3.60% | 148,618 | 305.11M |
| 168 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.18B | 3.91% | 468,469 | 7.70M |
| 169 | MMSI | Merit Medical Systems, Inc. | 4.15B | 3.61% | 174,875 | 1.52B |
| 170 | LGND | Ligand Pharmaceuticals Incorporated | 4.12B | 0.79% | 100,741 | 268.09M |
| 171 | DOCS | Doximity, Inc. | 4.09B | -1.58% | 1,446,341 | 637.78M |
| 172 | AMRX | Amneal Pharmaceuticals, Inc. | 4.06B | 3.25% | 274,887 | 3.02B |
| 173 | SYRE | Spyre Therapeutics, Inc. | 3.97B | -1.15% | 282,852 | - |
| 174 | IRTC | iRhythm Holdings, Inc. | 3.94B | 2.76% | 114,692 | 747.14M |
| 175 | VKTX | Viking Therapeutics, Inc. | 3.90B | -0.12% | 689,295 | - |
| 176 | NAMS | NewAmsterdam Pharma Company N.V. | 3.89B | -0.27% | 256,225 | 22.50M |
| 177 | ACAD | ACADIA Pharmaceuticals Inc. | 3.86B | 2.38% | 396,737 | 1.07B |
| 178 | GPCR | Structure Therapeutics Inc. | 3.84B | -0.91% | 401,082 | - |
| 179 | STVN | Stevanato Group S.p.A. | 3.78B | 1.61% | 228,413 | 1.39B |
| 180 | MMED | Minimed Group, Inc. | 3.74B | 0.98% | 237,181 | 2.89B |
| 181 | TMDX | TransMedics Group, Inc. | 3.71B | 0.87% | 467,439 | 605.49M |
| 182 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.61B | -3.68% | 208,823 | 677.56M |
| 183 | LIVN | LivaNova PLC | 3.54B | 1.75% | 277,432 | 1.39B |
| 184 | EWTX | Edgewise Therapeutics, Inc. | 3.53B | 1.35% | 160,277 | - |
| 185 | BKD | Brookdale Senior Living Inc. | 3.36B | 2.84% | 908,199 | 3.05B |
| 186 | LQDA | Liquidia Corporation | 3.35B | 1.87% | 347,875 | 158.32M |
| 187 | LEGN | Legend Biotech Corporation | 3.35B | 0.61% | 897,959 | 1.03B |
| 188 | TLX | Telix Pharmaceuticals Limited | 3.28B | 1.56% | 45,601 | 803.79M |
| 189 | TWST | Twist Bioscience Corporation | 3.20B | 4.21% | 448,522 | 391.56M |
| 190 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.13B | 2.44% | 509,758 | 588.99M |
| 191 | ORKA | Oruka Therapeutics, Inc. | 3.12B | 3.94% | 732,121 | - |
| 192 | ICUI | ICU Medical, Inc. | 3.11B | 3.98% | 71,176 | 2.23B |
| 193 | DNLI | Denali Therapeutics Inc. | 3.11B | 0.98% | 278,573 | - |
| 194 | HNGE | Hinge Health, Inc. | 3.07B | 2.66% | 148,012 | 587.86M |
| 195 | ARQT | Arcutis Biotherapeutics, Inc. | 3.03B | 5.05% | 377,023 | 376.07M |
| 196 | TARS | Tarsus Pharmaceuticals, Inc. | 3.02B | 3.21% | 189,574 | 451.36M |
| 197 | DYN | Dyne Therapeutics, Inc. | 3.01B | 0.50% | 333,306 | - |
| 198 | ALMS | Alumis Inc. | 3.00B | 5.78% | 426,974 | 24.05M |
| 199 | ITGR | Integer Holdings Corporation | 2.98B | 2.75% | 59,574 | 1.85B |
| 200 | SUPN | Supernus Pharmaceuticals, Inc. | 2.96B | 0.78% | 99,774 | 718.95M |
| 201 | TVTX | Travere Therapeutics, Inc. | 2.94B | 0.47% | 454,518 | 490.73M |
| 202 | TXG | 10x Genomics, Inc. | 2.91B | 4.54% | 701,034 | 642.82M |
| 203 | VERA | Vera Therapeutics, Inc. | 2.87B | 0.60% | 302,127 | - |
| 204 | PRVA | Privia Health Group, Inc. | 2.85B | 1.21% | 196,240 | 2.12B |
| 205 | TNGX | Tango Therapeutics, Inc. | 2.84B | 0.51% | 553,843 | 62.38M |
| 206 | CON | Concentra Group Holdings Parent, Inc. | 2.83B | 3.33% | 97,550 | 2.16B |
| 207 | HAE | Haemonetics Corporation | 2.82B | 1.97% | 145,525 | 1.32B |
| 208 | RCUS | Arcus Biosciences, Inc. | 2.82B | 1.95% | 137,834 | 247.00M |
| 209 | SLNO | Soleno Therapeutics, Inc. | 2.71B | 0.08% | 7,917,122 | 190.41M |
| 210 | IDYA | IDEAYA Biosciences, Inc. | 2.69B | -0.87% | 490,237 | 218.71M |
| 211 | WRBY | Warby Parker Inc. | 2.67B | 2.78% | 878,125 | 871.91M |
| 212 | NHC | National HealthCare Corporation | 2.65B | 1.92% | 31,894 | 1.52B |
| 213 | VCYT | Veracyte, Inc. | 2.64B | 3.30% | 179,550 | 517.15M |
| 214 | PBH | Prestige Consumer Healthcare Inc. | 2.61B | -0.90% | 271,840 | 1.10B |
| 215 | KOD | Kodiak Sciences Inc. | 2.59B | 0.50% | 400,882 | - |
| 216 | ELVN | Enliven Therapeutics, Inc. | 2.58B | 0.14% | 474,577 | - |
| 217 | LFST | LifeStance Health Group, Inc. | 2.57B | 2.73% | 385,655 | 1.42B |
| 218 | LMAT | LeMaitre Vascular, Inc. | 2.56B | 2.02% | 41,416 | 249.60M |
| 219 | RLAY | Relay Therapeutics, Inc. | 2.54B | 5.42% | 1,410,931 | 15.36M |
| 220 | IRON | Disc Medicine, Inc. | 2.54B | -0.60% | 64,813 | - |
| 221 | HCM | HUTCHMED (China) Limited | 2.53B | -1.53% | 26,230 | 548.51M |
| 222 | GRDN | Guardian Pharmacy Services, Inc. | 2.53B | 1.68% | 212,388 | 1.45B |
| 223 | BEAM | Beam Therapeutics Inc. | 2.49B | 2.57% | 666,392 | 139.74M |
| 224 | CLDX | Celldex Therapeutics, Inc. | 2.49B | 1.12% | 604,554 | 1.55M |
| 225 | IMNM | Immunome, Inc. | 2.48B | 1.44% | 238,063 | 6.94M |
| 226 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.46B | 2.24% | 2,130,264 | 874.84M |
| 227 | ZLAB | Zai Lab Limited | 2.45B | 3.38% | 617,549 | 460.16M |
| 228 | SRPT | Sarepta Therapeutics, Inc. | 2.40B | -0.78% | 805,163 | 2.20B |
| 229 | ACHC | Acadia Healthcare Company, Inc. | 2.40B | 2.84% | 653,682 | 3.31B |
| 230 | AAPG | Ascentage Pharma Group International | 2.40B | 0.99% | 794 | 82.08M |
| 231 | PAHC | Phibro Animal Health Corporation | 2.39B | 5.81% | 129,924 | 1.46B |
| 232 | HTFL | HeartFlow, Inc. | 2.39B | 3.54% | 315,715 | 176.03M |
| 233 | XRAY | DENTSPLY SIRONA Inc. | 2.36B | 2.52% | 1,755,825 | 3.68B |
| 234 | MLYS | Mineralys Therapeutics, Inc. | 2.34B | 0.18% | 353,688 | - |
| 235 | ADMA | ADMA Biologics, Inc. | 2.30B | 4.10% | 1,369,985 | 510.17M |
| 236 | NEOG | Neogen Corporation | 2.28B | 5.01% | 1,316,862 | 880.32M |
| 237 | RARE | Ultragenyx Pharmaceutical Inc. | 2.27B | -0.26% | 713,912 | 673.00M |
| 238 | ADPT | Adaptive Biotechnologies Corporation | 2.24B | 6.05% | 897,348 | 276.98M |
| 239 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | -0.12% | 568,563 | 158.18M |
| 240 | SNDX | Syndax Pharmaceuticals, Inc. | 2.15B | -0.97% | 330,240 | 172.35M |
| 241 | NKTR | Nektar Therapeutics | 2.15B | -1.67% | 386,744 | 55.23M |
| 242 | MANE | Veradermics, Incorporated | 2.14B | 0.83% | 223,239 | - |
| 243 | AUPH | Aurinia Pharmaceuticals Inc. | 2.10B | 0.09% | 290,776 | 283.06M |
| 244 | STOK | Stoke Therapeutics, Inc. | 2.08B | 4.29% | 429,845 | 184.42M |
| 245 | DFTX | Definium Therapeutics, Inc. | 2.07B | 0.97% | 609,039 | - |
| 246 | AGIO | Agios Pharmaceuticals, Inc. | 2.03B | -1.22% | 286,665 | 54.03M |
| 247 | SEM | Select Medical Holdings Corporation | 2.03B | 0.12% | 356,286 | 5.45B |
| 248 | TYRA | Tyra Biosciences, Inc. | 2.03B | -0.32% | 235,545 | - |
| 249 | GRAL | GRAIL, Inc. | 2.01B | -0.31% | 491,752 | 147.17M |
| 250 | BHC | Bausch Health Companies Inc. | 1.99B | 2.19% | 446,821 | 10.27B |
| 251 | ZYME | Zymeworks Inc. | 1.98B | 3.00% | 190,670 | 105.97M |
| 252 | AHG | Akso Health Group | 1.96B | 0.22% | 151,249 | 14.84M |
| 253 | WGS | GeneDx Holdings Corp. | 1.96B | -0.21% | 179,848 | 427.54M |
| 254 | GLPG | Galapagos NV | 1.88B | -0.86% | 50,952 | 1.31B |
| 255 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.86B | 3.32% | 407,007 | -665.00K |
| 256 | ANAB | AnaptysBio, Inc. | 1.85B | 3.61% | 132,633 | 234.60M |
| 257 | CAPR | Capricor Therapeutics, Inc. | 1.83B | -0.44% | 240,030 | 11.13M |
| 258 | PHVS | Pharvaris N.V. | 1.83B | 0.32% | 101,163 | - |
| 259 | OCUL | Ocular Therapeutix, Inc. | 1.83B | 0.60% | 1,486,805 | 51.95M |
| 260 | ESTA | Establishment Labs Holdings Inc. | 1.82B | 4.98% | 161,516 | 211.08M |
| 261 | MESO | Mesoblast Limited | 1.81B | 1.83% | 183,023 | 65.38M |
| 262 | RXRX | Recursion Pharmaceuticals, Inc. | 1.80B | 7.05% | 8,096,168 | 74.68M |
| 263 | MD | Pediatrix Medical Group, Inc. | 1.79B | 1.52% | 187,742 | 1.91B |
| 264 | AORT | Artivion, Inc. | 1.75B | 2.70% | 123,065 | 441.33M |
| 265 | VCEL | Vericel Corporation | 1.75B | 3.24% | 109,879 | 276.26M |
| 266 | ATEC | Alphatec Holdings, Inc. | 1.74B | 4.26% | 522,199 | 764.16M |
| 267 | INVA | Innoviva, Inc. | 1.73B | 0.56% | 175,948 | 411.33M |
| 268 | PVLA | Palvella Therapeutics, Inc. | 1.72B | 0.16% | 91,097 | - |
| 269 | ADUS | Addus HomeCare Corporation | 1.71B | 1.12% | 55,556 | 1.42B |
| 270 | SION | Sionna Therapeutics, Inc. | 1.71B | 3.17% | 82,241 | - |
| 271 | AXGN | Axogen, Inc. | 1.69B | 5.13% | 341,364 | 225.21M |
| 272 | NRIX | Nurix Therapeutics, Inc. | 1.68B | -0.61% | 655,572 | 71.78M |
| 273 | TRVI | Trevi Therapeutics, Inc. | 1.68B | -0.23% | 390,043 | - |
| 274 | ANIP | ANI Pharmaceuticals, Inc. | 1.67B | 0.94% | 172,074 | 883.37M |
| 275 | AHCO | AdaptHealth Corp. | 1.67B | 3.06% | 328,160 | 3.24B |
| 276 | SGRY | Surgery Partners, Inc. | 1.67B | 3.12% | 418,046 | 3.31B |
| 277 | HRMY | Harmony Biosciences Holdings, Inc. | 1.65B | 2.92% | 359,358 | 868.45M |
| 278 | OMCL | Omnicell, Inc. | 1.64B | 4.61% | 88,913 | 1.18B |
| 279 | IMCR | Immunocore Holdings plc | 1.64B | 1.19% | 236,738 | 400.02M |
| 280 | NTLA | Intellia Therapeutics, Inc. | 1.64B | 2.29% | 1,269,292 | 67.67M |
| 281 | OCS | Oculis Holding AG | 1.62B | 3.92% | 71,238 | 1.51M |
| 282 | RAPP | Rapport Therapeutics, Inc. | 1.61B | 0.39% | 37,296 | - |
| 283 | DMRA | Damora Therapeutics, Inc. | 1.59B | 7.75% | 49,025 | - |
| 284 | OGN | Organon & Co. | 1.56B | -2.21% | 1,467,899 | 6.22B |
| 285 | INSP | Inspire Medical Systems, Inc. | 1.55B | -1.10% | 242,892 | 911.98M |
| 286 | NUVB | Nuvation Bio Inc. | 1.55B | 0.22% | 1,024,851 | 62.90M |
| 287 | SNDA | Sonida Senior Living, Inc. | 1.54B | 2.76% | 269,036 | 336.39M |
| 288 | UFPT | UFP Technologies, Inc. | 1.53B | 5.28% | 110,276 | 602.80M |
| 289 | MBX | MBX Biosciences, Inc. | 1.53B | 6.74% | 191,713 | - |
| 290 | GENB | Generate Biomedicines, Inc. | 1.53B | 1.48% | 132,599 | 31.89M |
| 291 | SVRA | Savara Inc. | 1.52B | 3.72% | 397,983 | - |
| 292 | ARDX | Ardelyx, Inc. | 1.52B | 3.87% | 1,099,552 | 407.32M |
| 293 | VIR | Vir Biotechnology, Inc. | 1.50B | 2.40% | 595,231 | 68.56M |
| 294 | PRGO | Perrigo Company plc | 1.48B | 1.94% | 826,522 | 4.25B |
| 295 | ATRC | AtriCure, Inc. | 1.47B | 0.66% | 195,533 | 534.53M |
| 296 | VRDN | Viridian Therapeutics, Inc. | 1.47B | 2.72% | 1,423,006 | 70.85M |
| 297 | PGEN | Precigen, Inc. | 1.45B | -0.61% | 1,193,479 | 9.68M |
| 298 | AVAH | Aveanna Healthcare Holdings Inc. | 1.44B | 2.95% | 699,139 | 2.43B |
| 299 | NBTX | Nanobiotix S.A. | 1.44B | -0.10% | 54,747 | 38.27M |
| 300 | MAZE | Maze Therapeutics, Inc. | 1.42B | 0.71% | 323,257 | 2.50M |
| 301 | BHVN | Biohaven Ltd. | 1.42B | 1.62% | 429,277 | - |
| 302 | BCAX | Bicara Therapeutics Inc. | 1.41B | 1.06% | 95,152 | - |
| 303 | ASTH | Astrana Health, Inc. | 1.39B | 1.44% | 187,803 | 3.18B |
| 304 | OLMA | Olema Pharmaceuticals, Inc. | 1.38B | 4.20% | 300,677 | - |
| 305 | IMTX | Immatics N.V. | 1.38B | 0.68% | 84,374 | 56.67M |
| 306 | GLUE | Monte Rosa Therapeutics, Inc. | 1.38B | 0.99% | 211,109 | 123.67M |
| 307 | ENOV | Enovis Corporation | 1.38B | 6.66% | 186,841 | 2.25B |
| 308 | PRCT | PROCEPT BioRobotics Corporation | 1.38B | 5.65% | 807,451 | 308.05M |
| 309 | IOVA | Iovance Biotherapeutics, Inc. | 1.38B | 0.90% | 5,139,390 | 263.50M |
| 310 | ATAI | AtaiBeckley Inc. | 1.38B | -0.26% | 2,071,902 | 4.09M |
| 311 | HCSG | Healthcare Services Group, Inc. | 1.37B | 3.56% | 207,733 | 1.84B |
| 312 | ARDT | Ardent Health, Inc. | 1.36B | 5.60% | 112,963 | 6.32B |
| 313 | PGNY | Progyny, Inc. | 1.36B | 0.93% | 166,318 | 1.29B |
| 314 | NVAX | Novavax, Inc. | 1.35B | 4.01% | 1,635,709 | 1.12B |
| 315 | PLSE | Pulse Biosciences, Inc. | 1.35B | -0.55% | 184,144 | 350.00K |
| 316 | HROW | Harrow, Inc. | 1.35B | 2.17% | 207,322 | 272.30M |
| 317 | WVE | Wave Life Sciences Ltd. | 1.34B | 0.42% | 800,678 | 42.73M |
| 318 | TNDM | Tandem Diabetes Care, Inc. | 1.33B | 6.40% | 598,274 | 1.01B |
| 319 | TSHA | Taysha Gene Therapies, Inc. | 1.32B | 0.33% | 366,527 | 9.77M |
| 320 | MLTX | MoonLake Immunotherapeutics | 1.29B | 5.62% | 586,918 | - |
| 321 | CRVS | Corvus Pharmaceuticals, Inc. | 1.26B | 4.56% | 201,131 | - |
| 322 | ZBIO | Zenas BioPharma, Inc. | 1.25B | -6.49% | 230,010 | 10.00M |
| 323 | NVCR | NovoCure Limited | 1.25B | 6.04% | 355,124 | 655.35M |
| 324 | IRMD | IRADIMED CORPORATION | 1.23B | 3.33% | 31,510 | 83.81M |
| 325 | KMTS | Kestra Medical Technologies, Ltd. | 1.21B | 6.05% | 111,809 | 83.72M |
| 326 | EYPT | EyePoint, Inc. | 1.18B | 4.20% | 445,854 | 31.37M |
| 327 | NNNN | Anbio Biotechnology | 1.17B | -2.34% | 5,957 | 8.65M |
| 328 | USPH | U.S. Physical Therapy, Inc. | 1.16B | 2.85% | 18,839 | 773.34M |
| 329 | PHAR | Pharming Group N.V. | 1.15B | 0.76% | 22,562 | 376.13M |
| 330 | ALVO | Alvotech | 1.14B | 7.63% | 225,154 | 588.90M |
| 331 | DBVT | DBV Technologies S.A. | 1.14B | 5.62% | 59,356 | 5.64M |
| 332 | CNMD | CONMED Corporation | 1.13B | 6.25% | 92,179 | 1.37B |
| 333 | AVBP | ArriVent BioPharma, Inc. | 1.12B | 0.18% | 123,988 | - |
| 334 | INNV | InnovAge Holding Corp. | 1.11B | 4.06% | 91,371 | 915.37M |
| 335 | SEPN | Septerna, Inc. | 1.11B | -0.32% | 61,041 | 45.95M |
| 336 | GERN | Geron Corporation | 1.10B | -1.72% | 8,214,472 | 183.88M |
| 337 | QDEL | QuidelOrtho Corporation | 1.09B | 6.88% | 382,844 | 2.73B |
| 338 | PNTG | The Pennant Group, Inc. | 1.09B | 2.06% | 71,319 | 947.71M |
| 339 | MPLT | MapLight Therapeutics, Inc. | 1.09B | 2.53% | 169,947 | - |
| 340 | NEO | NeoGenomics, Inc. | 1.09B | 3.60% | 294,717 | 727.33M |
| 341 | BFLY | Butterfly Network, Inc. | 1.07B | 3.70% | 1,689,899 | 97.61M |
| 342 | COLL | Collegium Pharmaceutical, Inc. | 1.06B | 2.08% | 197,346 | 780.57M |
| 343 | STAA | STAAR Surgical Company | 1.05B | 0.85% | 298,186 | 239.44M |
| 344 | XERS | Xeris Biopharma Holdings, Inc. | 1.05B | 3.92% | 638,801 | 291.85M |
| 345 | ABCL | AbCellera Biologics Inc. | 1.04B | 4.39% | 1,001,073 | 75.13M |
| 346 | QURE | uniQure N.V. | 1.04B | -2.63% | 455,696 | 16.10M |
| 347 | AZTA | Azenta, Inc. | 1.03B | 3.09% | 336,993 | 595.03M |
| 348 | INBX | Inhibrx Biosciences, Inc. | 1.01B | 10.91% | 58,370 | 1.30M |
| 349 | CLOV | Clover Health Investments, Corp. | 1.01B | 1.05% | 3,050,443 | 1.92B |
| 350 | IVA | Inventiva S.A. | 1.01B | 0.09% | 106,357 | 9.31M |
| 351 | KALV | KalVista Pharmaceuticals, Inc. | 1.00B | -2.83% | 328,817 | 73.62M |
| 352 | EVO | Evotec SE | 969.55M | 4.98% | 85,814 | 887.40M |
| 353 | ANNX | Annexon, Inc. | 967.66M | 0.67% | 801,857 | - |
| 354 | CMPX | Compass Therapeutics, Inc. | 963.47M | 0.75% | 485,819 | 850.00K |
| 355 | EVMN | Evommune, Inc. | 962.05M | 7.75% | 165,824 | 13.00M |
| 356 | SSII | SS Innovations International, Inc. | 961.71M | 0.63% | 9,902 | 42.48M |
| 357 | TDOC | Teladoc Health, Inc. | 958.88M | 1.03% | 1,499,319 | 2.53B |
| 358 | BLFS | BioLife Solutions, Inc. | 953.93M | 3.24% | 140,611 | 96.21M |
| 359 | CRON | Cronos Group Inc. | 953.33M | 1.79% | 253,195 | 146.59M |
| 360 | CTMX | CytomX Therapeutics, Inc. | 946.86M | 1.86% | 3,491,702 | 76.20M |
| 361 | AKTS | Aktis Oncology, Inc. | 940.24M | 1.73% | 56,024 | 6.50M |
| 362 | PHAT | Phathom Pharmaceuticals, Inc. | 935.34M | 2.77% | 339,664 | 175.11M |
| 363 | PCRX | Pacira BioSciences, Inc. | 934.51M | 2.44% | 100,189 | 726.41M |
| 364 | AMPH | Amphastar Pharmaceuticals, Inc. | 931.00M | -0.29% | 151,452 | 719.89M |
| 365 | CDNA | CareDx, Inc. | 923.94M | 2.09% | 184,136 | 379.81M |
| 366 | OPK | OPKO Health, Inc. | 922.27M | 3.85% | 1,300,066 | 606.88M |
| 367 | GHRS | GH Research PLC | 919.90M | 1.02% | 19,587 | - |
| 368 | LMRI | Lumexa Imaging Holdings, Inc. | 913.04M | 5.32% | 461,482 | 1.02B |
| 369 | URGN | UroGen Pharma Ltd. | 911.33M | 3.83% | 254,613 | 109.79M |
| 370 | ORIC | ORIC Pharmaceuticals, Inc. | 906.23M | 1.80% | 484,232 | - |
| 371 | XNCR | Xencor, Inc. | 905.73M | 0.32% | 272,699 | 125.58M |
| 372 | FTRE | Fortrea Holdings Inc. | 897.60M | 0.95% | 332,787 | 2.72B |
| 373 | VOR | Vor Biopharma Inc. | 894.06M | -2.08% | 1,034,442 | - |
| 374 | CGEM | Cullinan Therapeutics, Inc. | 891.55M | -0.87% | 173,627 | - |
| 375 | JANX | Janux Therapeutics, Inc. | 885.71M | -2.48% | 207,079 | 10.00M |
| 376 | SLS | SELLAS Life Sciences Group, Inc. | 874.57M | 7.98% | 2,311,054 | - |
| 377 | INMD | InMode Ltd. | 874.35M | 1.10% | 117,328 | 370.50M |
| 378 | CERT | Certara, Inc. | 871.65M | 1.16% | 818,472 | 418.84M |
| 379 | TALK | Talkspace, Inc. | 864.62M | 0.29% | 935,596 | 228.87M |
| 380 | SDGR | Schrödinger, Inc. | 863.75M | 2.72% | 544,727 | 255.87M |
| 381 | ABUS | Arbutus Biopharma Corporation | 860.10M | -1.35% | 1,377,845 | 14.08M |
| 382 | TBPH | Theravance Biopharma, Inc. | 858.64M | 0.69% | 104,907 | 107.46M |
| 383 | SANA | Sana Biotechnology, Inc. | 857.98M | 2.06% | 827,972 | - |
| 384 | JBIO | Jade Biosciences, Inc. | 847.25M | 5.01% | 312,380 | - |
| 385 | MRVI | Maravai LifeSciences Holdings, Inc. | 814.90M | 9.69% | 1,012,425 | 185.74M |
| 386 | MNKD | MannKind Corporation | 807.22M | 1.95% | 1,069,340 | 348.97M |
| 387 | SPRY | ARS Pharmaceuticals, Inc. | 804.31M | -0.61% | 399,083 | 84.28M |
| 388 | OMER | Omeros Corporation | 795.56M | 0.64% | 394,761 | - |
| 389 | TLRY | Tilray Brands, Inc. | 793.83M | 5.73% | 1,811,744 | 858.28M |
| 390 | DSGN | Design Therapeutics, Inc. | 782.62M | 3.85% | 119,655 | - |
| 391 | SLDB | Solid Biosciences Inc. | 780.24M | 2.45% | 180,915 | - |
| 392 | KURA | Kura Oncology, Inc. | 777.30M | -0.23% | 408,834 | 67.48M |
| 393 | BIOA | BioAge Labs, Inc. | 776.65M | -0.62% | 149,582 | 9.00M |
| 394 | MGTX | MeiraGTx Holdings plc | 768.85M | -0.74% | 294,399 | 81.39M |
| 395 | IART | Integra LifeSciences Holdings Corporation | 768.46M | 5.68% | 183,691 | 1.64B |
| 396 | BVS | Bioventus Inc. | 768.35M | 4.52% | 92,391 | 568.09M |
| 397 | TENX | Tenax Therapeutics, Inc. | 754.76M | 2.84% | 170,136 | - |
| 398 | OMDA | Omada Health, Inc. | 754.25M | 3.23% | 210,701 | 260.21M |
| 399 | CSTL | Castle Biosciences, Inc. | 752.79M | 1.97% | 60,929 | 344.23M |
| 400 | DRUG | Bright Minds Biosciences Inc. | 750.27M | 4.07% | 102,761 | - |
| 401 | NUTX | Nutex Health Inc. | 744.15M | 3.78% | 105,007 | 875.26M |
| 402 | CMPS | COMPASS Pathways plc | 740.02M | 3.61% | 758,557 | - |
| 403 | GDRX | GoodRx Holdings, Inc. | 739.96M | 5.37% | 458,188 | 796.85M |
| 404 | SGP | SpyGlass Pharma, Inc. | 734.05M | 4.22% | 48,325 | - |
| 405 | AMN | AMN Healthcare Services, Inc. | 727.12M | 0.97% | 141,945 | 2.73B |
| 406 | ARVN | Arvinas, Inc. | 720.84M | -0.88% | 242,270 | 262.60M |
| 407 | RLMD | Relmada Therapeutics, Inc. | 718.48M | 1.48% | 270,627 | - |
| 408 | EHAB | Enhabit, Inc. | 709.87M | 0.04% | 433,150 | 1.06B |
| 409 | LXRX | Lexicon Pharmaceuticals, Inc. | 709.67M | 4.69% | 841,158 | 49.80M |
| 410 | CBLL | CeriBell, Inc. | 706.53M | 5.04% | 77,034 | 89.06M |
| 411 | ETON | Eton Pharmaceuticals, Inc. | 703.94M | 2.95% | 113,929 | 79.95M |
| 412 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 699.49M | 4.05% | 168,657 | - |
| 413 | ANRO | Alto Neuroscience, Inc. | 698.01M | 2.34% | 91,978 | - |
| 414 | PSNL | Personalis, Inc. | 678.31M | 5.02% | 920,490 | 69.65M |
| 415 | GYRE | Gyre Therapeutics, Inc. | 661.11M | 1.69% | 34,668 | 116.59M |
| 416 | AVNS | Avanos Medical, Inc. | 653.43M | 2.63% | 66,913 | 701.20M |
| 417 | ALLO | Allogene Therapeutics, Inc. | 653.32M | 2.29% | 1,413,609 | 22.00K |
| 418 | LBRX | LB Pharmaceuticals Inc | 648.42M | 1.30% | 38,373 | - |
| 419 | DRTS | Alpha Tau Medical Ltd. | 642.47M | 2.24% | 254,799 | - |
| 420 | OCGN | Ocugen, Inc. | 640.32M | 8.91% | 2,371,082 | 4.41M |
| 421 | PRME | Prime Medicine, Inc. | 618.89M | 2.49% | 633,684 | 4.63M |
| 422 | SIBN | SI-BONE, Inc. | 616.55M | 6.00% | 279,839 | 200.93M |
| 423 | HSTM | HealthStream, Inc. | 612.08M | 1.46% | 34,740 | 304.06M |
| 424 | ESPR | Esperion Therapeutics, Inc. | 609.92M | 2.81% | 1,412,420 | 403.14M |
| 425 | MDXG | MiMedx Group, Inc. | 600.21M | 4.66% | 260,714 | 418.63M |
| 426 | CBIO | Crescent Biopharma, Inc. | 595.03M | -6.74% | 38,585 | 10.84M |
| 427 | CTKB | Cytek Biosciences, Inc. | 593.90M | 0.43% | 165,846 | 201.49M |
| 428 | IRWD | Ironwood Pharmaceuticals, Inc. | 582.12M | 3.18% | 444,655 | 296.15M |
| 429 | REPL | Replimune Group, Inc. | 573.88M | -10.90% | 2,450,158 | - |
| 430 | PROK | ProKidney Corp. | 573.64M | 3.83% | 450,108 | 893.00K |
| 431 | CRMD | CorMedix Inc. | 571.14M | 0.77% | 287,128 | 311.71M |
| 432 | TECX | Tectonic Therapeutic, Inc. | 570.06M | 4.55% | 54,420 | - |
| 433 | ZVRA | Zevra Therapeutics, Inc. | 566.86M | -0.26% | 235,329 | 106.47M |
| 434 | TCMD | Tactile Systems Technology, Inc. | 565.12M | 3.28% | 83,290 | 329.52M |
| 435 | PRTA | Prothena Corporation plc | 562.55M | 0.87% | 117,271 | 9.68M |
| 436 | PHR | Phreesia, Inc. | 549.91M | -0.11% | 586,189 | 480.59M |
| 437 | KYTX | Kyverna Therapeutics, Inc. | 547.72M | -2.89% | 483,300 | - |
| 438 | BWAY | BrainsWay Ltd. | 544.09M | 7.10% | 139,949 | 52.23M |
| 439 | ZURA | Zura Bio Limited | 543.19M | 1.33% | 195,411 | - |
| 440 | LRMR | Larimar Therapeutics, Inc. | 542.79M | 3.67% | 375,938 | - |
| 441 | RIGL | Rigel Pharmaceuticals, Inc. | 540.71M | 1.88% | 127,585 | 294.28M |
| 442 | ACRS | Aclaris Therapeutics, Inc. | 538.61M | 3.33% | 286,276 | 7.83M |
| 443 | LYEL | Lyell Immunopharma, Inc. | 535.15M | 5.33% | 22,797 | 36.00K |
| 444 | EMBC | Embecta Corp. | 533.27M | 1.98% | 87,055 | 1.08B |
| 445 | UPB | Upstream Bio, Inc. | 531.68M | 0.72% | 136,393 | 2.85M |
| 446 | FULC | Fulcrum Therapeutics, Inc. | 529.47M | 1.53% | 167,908 | 80.00M |
| 447 | FDMT | 4D Molecular Therapeutics, Inc. | 519.19M | -0.68% | 298,931 | 85.21M |
| 448 | VALN | Valneva SE | 517.72M | 5.49% | 25,188 | 205.07M |
| 449 | AGMB | AgomAb Therapeutics NV | 514.90M | 0.52% | 42,975 | - |
| 450 | AVR | Anteris Technologies Global Corp. | 512.60M | 2.07% | 270,096 | 1.91M |
| 451 | AQST | Aquestive Therapeutics, Inc. | 512.59M | 1.69% | 735,221 | 44.55M |
| 452 | TRDA | Entrada Therapeutics, Inc. | 509.04M | 2.09% | 48,838 | 25.42M |
| 453 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 454 | NPCE | NeuroPace, Inc. | 498.61M | 2.07% | 43,695 | 99.99M |
| 455 | FBRX | Forte Biosciences, Inc. | 494.54M | 0.69% | 36,280 | - |
| 456 | OFIX | Orthofix Medical Inc. | 494.18M | 5.12% | 42,293 | 822.31M |
| 457 | CATX | Perspective Therapeutics, Inc. | 493.33M | -0.92% | 183,227 | 884.00K |
| 458 | EIKN | Eikon Therapeutics, Inc. | 491.58M | 3.42% | 137,147 | - |
| 459 | STTK | Shattuck Labs, Inc. | 488.78M | 0.74% | 199,795 | 1.00M |
| 460 | VSTM | Verastem, Inc. | 486.17M | 1.56% | 451,305 | 30.91M |
| 461 | AVIR | Atea Pharmaceuticals, Inc. | 485.60M | 2.09% | 104,317 | - |
| 462 | ENGN | enGene Holdings Inc. | 482.99M | -1.64% | 36,784 | - |
| 463 | CTNM | Contineum Therapeutics, Inc. | 480.89M | 1.18% | 41,261 | - |
| 464 | KMDA | Kamada Ltd. | 476.75M | 2.42% | 8,741 | 180.46M |
| 465 | ADCT | ADC Therapeutics SA | 475.15M | 0.54% | 89,205 | 81.36M |
| 466 | VTVT | vTv Therapeutics Inc. | 473.05M | -0.34% | 43,505 | 17.00K |
| 467 | YDES | YD Bio Limited | 470.44M | -4.15% | 8,561 | 510.36K |
| 468 | FLGT | Fulgent Genetics, Inc. | 469.30M | 2.26% | 117,167 | 322.67M |
| 469 | ASMB | Assembly Biosciences, Inc. | 467.47M | 3.29% | 31,578 | 72.30M |
| 470 | LXEO | Lexeo Therapeutics, Inc. | 466.01M | -0.32% | 410,024 | - |
| 471 | IMMX | Immix Biopharma, Inc. | 465.98M | -3.30% | 259,562 | - |
| 472 | VREX | Varex Imaging Corporation | 464.89M | 4.72% | 69,380 | 854.40M |
| 473 | ABSI | Absci Corporation | 462.12M | 3.42% | 1,327,319 | 2.80M |
| 474 | MYGN | Myriad Genetics, Inc. | 454.45M | 2.53% | 273,300 | 824.50M |
| 475 | ARMP | Armata Pharmaceuticals, Inc. | 452.78M | 3.43% | 48,349 | 4.90M |
| 476 | RGNX | REGENXBIO Inc. | 452.68M | -0.34% | 187,656 | 170.44M |
| 477 | PACB | Pacific Biosciences of California, Inc. | 449.98M | 3.47% | 3,125,824 | 160.01M |
| 478 | ALT | Altimmune, Inc. | 443.66M | 0.89% | 905,201 | 41.00K |
| 479 | VNDA | Vanda Pharmaceuticals Inc. | 441.54M | 0.27% | 559,628 | 216.11M |
| 480 | AURA | Aura Biosciences, Inc. | 436.22M | 2.56% | 101,029 | - |
| 481 | AUNA | Auna S.A. | 435.20M | 1.20% | 80,458 | 1.30B |
| 482 | BBNX | Beta Bionics, Inc. | 433.61M | 0.41% | 214,325 | 100.25M |
| 483 | EBS | Emergent BioSolutions Inc. | 429.68M | 5.99% | 193,958 | 742.90M |
| 484 | ANGO | AngioDynamics, Inc. | 429.53M | 6.24% | 158,792 | 313.73M |
| 485 | STRO | Sutro Biopharma, Inc. | 425.61M | -0.08% | 49,829 | 102.48M |
| 486 | CYH | Community Health Systems, Inc. | 423.01M | 4.29% | 552,495 | 12.49B |
| 487 | EPRX | Eupraxia Pharmaceuticals Inc. | 416.76M | -0.74% | 51,936 | - |
| 488 | KIDS | OrthoPediatrics Corp. | 412.80M | 3.62% | 29,089 | 236.35M |
| 489 | NAUT | Nautilus Biotechnology, Inc. | 411.33M | 4.17% | 145,680 | - |
| 490 | IPSC | Century Therapeutics, Inc. | 406.17M | - | 557,970 | 109.16M |
| 491 | XOMA | XOMA Royalty Corporation | 405.91M | -1.49% | 65,501 | 52.15M |
| 492 | DNA | Ginkgo Bioworks Holdings, Inc. | 404.83M | 1.98% | 362,736 | 170.16M |
| 493 | ANL | Adlai Nortye Ltd. | 404.43M | 11.84% | 607,009 | -1.35M |
| 494 | NRC | National Research Corporation | 403.75M | 4.17% | 20,940 | 137.39M |
| 495 | WEAV | Weave Communications, Inc. | 402.29M | 0.10% | 560,614 | 239.02M |
| 496 | ENTA | Enanta Pharmaceuticals, Inc. | 400.18M | 2.68% | 22,343 | 66.98M |
| 497 | AUTL | Autolus Therapeutics plc | 392.56M | 8.46% | 945,202 | 75.39M |
| 498 | NMRA | Neumora Therapeutics, Inc. | 391.39M | 0.94% | 392,482 | - |
| 499 | RCKT | Rocket Pharmaceuticals, Inc. | 391.21M | 3.02% | 1,062,906 | - |
| 500 | LCTX | Lineage Cell Therapeutics, Inc. | 389.82M | 2.96% | 550,066 | 14.56M |